XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 287 $ 24,713 $ (11,769) $ 13,231
Beginning balance, shares at Dec. 31, 2021 2,874,999      
Net loss
Ending balance, value at Mar. 31, 2022 [1],[2] $ 287 24,713 (11,769) 13,231
Ending balance, shares at Mar. 31, 2022 2,874,999      
Beginning balance, value at Dec. 31, 2022 $ 321 (4,822,763) (4,822,442)
Beginning balance, shares at Dec. 31, 2022 3,218,499      
Accretion of common stock to redemption value   (1,906,712) (1,906,712)
Net loss 71,378 71,378
Ending balance, value at Mar. 31, 2023 $ 321 $ (6,658,097) $ (6,657,776)
Ending balance, shares at Mar. 31, 2023 3,218,499      
[1] Includes up to 375,000 shares of common stock subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part (see Note 5). As a result of the underwriters’ full exercise of their over-allotment option on April 27, 2022, no insider shares are currently subject to forfeiture.
[2] Shares have been retroactively restated to reflect the surrender of 1,150,000 shares without consideration by the sponsor on March 7, 2022 and a dividend, payable in shares of common stock, of two-thirds of one share of common stock for each share of common stock issued and outstanding on April 5, 2022 (Note 7).